Company Filing History:
Years Active: 2012-2014
Title: The Innovative Contributions of Jeffrey Millard
Introduction
Jeffrey Millard is a notable inventor based in Seattle, WA. He has made significant contributions to the field of immunotherapy, particularly in the development of vaccines for cancer treatment. With a total of 2 patents, Millard's work is paving the way for advancements in medical science.
Latest Patents
Millard's latest patents include a MUC1 based glycolipopeptide vaccine with adjuvant. This innovative formulation comprises liposomal glycolipopeptidic vaccine formulations that include an adjuvant and an immunogen. The goal of this invention is to enhance immunotherapy and treatment options for cancer patients.
Career Highlights
Throughout his career, Jeffrey Millard has been associated with Oncothyreon Inc., a company dedicated to developing innovative cancer therapies. His work at the company has focused on creating effective solutions that can improve patient outcomes in cancer treatment.
Collaborations
Millard collaborates with talented professionals in his field, including Scott Peterson and Linda Pestano. These partnerships enhance the research and development efforts at Oncothyreon Inc., contributing to the advancement of cancer therapies.
Conclusion
Jeffrey Millard's contributions to the field of immunotherapy through his patents and work at Oncothyreon Inc. highlight his commitment to improving cancer treatment. His innovative spirit and collaborative efforts are essential in the ongoing fight against cancer.